{
  "id": "2c31ffff1c4af3e9",
  "title": "Remibrutinib Improves Outcomes in Patients With Chronic Inducible Urticaria",
  "description": "20260218T210000Z",
  "content": "",
  "source": "empr.com",
  "source_url": "https://www.empr.com/news/remibrutinib-improves-outcomes-in-patients-with-chronic-inducible-urticaria/",
  "published_at": "20260218T210000Z",
  "fetched_at": "2026-02-19T00:30:34.211663+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "United States",
  "raw_data": {
    "url": "https://www.empr.com/news/remibrutinib-improves-outcomes-in-patients-with-chronic-inducible-urticaria/",
    "url_mobile": "",
    "title": "Remibrutinib Improves Outcomes in Patients With Chronic Inducible Urticaria",
    "seendate": "20260218T210000Z",
    "socialimage": "https://www.empr.com/wp-content/uploads/sites/7/2024/01/MPR_1200x675.png",
    "domain": "empr.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}